Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

Primary cervical screening with high risk human papillomavirus testing: observational study.

Rebolj M, Rimmer J, Denton K, Tidy J, Mathews C, Ellis K, Smith J, Evans C, Giles T, Frew V, Tyler X, Sargent A, Parker J, Holbrook M, Hunt K, Tidbury P, Levine T, Smith D, Patnick J, Stubbs R, Moss S, Kitchener H.

BMJ. 2019 Feb 6;364:l240. doi: 10.1136/bmj.l240.

2.

Systematic review of health-related quality of life and patient-reported outcome measures in gestational trophoblastic disease: a parallel synthesis approach.

Ireson J, Jones G, Winter MC, Radley SC, Hancock BW, Tidy JA.

Lancet Oncol. 2018 Jan;19(1):e56-e64. doi: 10.1016/S1470-2045(17)30686-1. Review.

PMID:
29304364
3.

Conservative management of CIN2: National Audit of British Society for Colposcopy and Cervical Pathology members' opinion.

Macdonald M, Smith JHF, Tidy JA, Palmer JE.

J Obstet Gynaecol. 2018 Apr;38(3):388-394. doi: 10.1080/01443615.2017.1316973. Epub 2017 Dec 6.

PMID:
29212399
4.

Development and Psychometric Testing of an Electronic Patient-Reported Outcome Tool for Vulval Disorders (ePAQ-Vulva).

Gray TG, Alexander C, Jones GL, Tidy JA, Palmer JE, Radley SC.

J Low Genit Tract Dis. 2017 Oct;21(4):319-326. doi: 10.1097/LGT.0000000000000345.

PMID:
28953126
5.

Influence of high risk HPV genotype on colposcopic performance: A large prospective study demonstrates improved detection of disease with ZedScan I, particularly in non-HPV 16 patients.

Macdonald MC, Brown BH, Lyon RE, Healey TJ, Palmer JE, Tidy JA.

Eur J Obstet Gynecol Reprod Biol. 2017 Apr;211:194-198. doi: 10.1016/j.ejogrb.2017.02.020. Epub 2017 Feb 20.

PMID:
28292693
7.

Second Curettage for Low-Risk Nonmetastatic Gestational Trophoblastic Neoplasia.

Osborne RJ, Filiaci VL, Schink JC, Mannel RS, Behbakht K, Hoffman JS, Spirtos NM, Chan JK, Tidy JA, Miller DS.

Obstet Gynecol. 2016 Sep;128(3):535-42. doi: 10.1097/AOG.0000000000001554.

8.

Management and Outcomes of Patients with Stage I and IlIl Low-Risk Gestational Trophoblastic Neoplasia Treated in Sheffield, UK, from 1997-2006.

Macdonald MC, Hancock BW, Winter MC, Coleman RE, Tidy JA.

J Reprod Med. 2016 Aug;61(7-8):341-346.

PMID:
30408379
9.

Evolution of a Teenage and Young Adult Service, in Sheffield, U.K., for Patients with Gestational Trophoblastic Neoplasia.

Gillett S, Singh K, Ireson J, Hills A, Winter M, Tidy J, Logan R, Hancock B.

J Reprod Med. 2016 May-Jun;61(5-6):235-7.

PMID:
27424365
10.

First-line chemotherapy in low-risk gestational trophoblastic neoplasia.

Lawrie TA, Alazzam M, Tidy J, Hancock BW, Osborne R.

Cochrane Database Syst Rev. 2016 Jun 9;(6):CD007102. doi: 10.1002/14651858.CD007102.pub4. Review.

PMID:
27281496
11.

Can We Be Less Radical with Surgery for Early Cervical Cancer?

Macdonald MC, Tidy JA.

Curr Oncol Rep. 2016 Mar;18(3):16. doi: 10.1007/s11912-016-0501-5. Review.

PMID:
26838586
12.

Early and late vulval cancer recurrences: Are they different?

Ragupathy K, Grandidge L, Strelley K, Wang H, Tidy J.

J Obstet Gynaecol. 2016 May;36(4):518-21. doi: 10.3109/01443615.2015.1107529. Epub 2016 Jan 22.

PMID:
26800292
13.

Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia.

Alazzam M, Tidy J, Osborne R, Coleman R, Hancock BW, Lawrie TA.

Cochrane Database Syst Rev. 2016 Jan 13;(1):CD008891. doi: 10.1002/14651858.CD008891.pub3. Review.

PMID:
26760424
14.

The impact of surgery for vulval cancer upon health-related quality of life and pelvic floor outcomes during the first year of treatment: a longitudinal, mixed methods study.

Jones GL, Jacques RM, Thompson J, Wood HJ, Hughes J, Ledger W, Alazzam M, Radley SC, Tidy JA.

Psychooncology. 2016 Jun;25(6):656-62. doi: 10.1002/pon.3992. Epub 2015 Sep 25.

15.

The Role of Computed Tomography Scanning of the Thorax in the Initial Assessment of Gestational Trophoblastic Neoplasia.

Price JM, Lo C, Abdi S, Winter MC, Coleman RE, Tidy J, Hancock BW.

Int J Gynecol Cancer. 2015 Nov;25(9):1731-6. doi: 10.1097/IGC.0000000000000534.

PMID:
26270122
16.

Use of electrical impedance spectroscopy to detect malignant and potentially malignant oral lesions.

Murdoch C, Brown BH, Hearnden V, Speight PM, D'Apice K, Hegarty AM, Tidy JA, Healey TJ, Highfield PE, Thornhill MH.

Int J Nanomedicine. 2014 Sep 23;9:4521-32. doi: 10.2147/IJN.S64087. eCollection 2014.

17.

Evolution of a specialist gestational trophoblastic disease service with a major nursing component: the Sheffield, United Kingdom, experience.

Ireson J, Singh K, Gillett S, Hills A, Everard J, Winter M, Coleman RE, Tidy J, Hancock BW.

J Reprod Med. 2014 May-Jun;59(5-6):195-8.

PMID:
24937956
18.

Management and survival of patients with FIGO high-risk gestational trophoblastic neoplasia: the U.K. experience, 1995-2010.

Agarwal R, Alifrangis C, Everard J, Savage PM, Short D, Tidy J, Fisher RA, Sebire NJ, Harvey R, Hancock BW, Coleman RE, Seckl MJ.

J Reprod Med. 2014 Jan-Feb;59(1-2):7-12.

PMID:
24597279
19.

Understanding the impact of the treatment pathway upon the health-related quality of life of women with newly diagnosed endometrial cancer - a qualitative study.

Bowes H, Jones G, Thompson J, Alazzam M, Wood H, Hinchliff S, Ledger W, Tidy J.

Eur J Oncol Nurs. 2014 Apr;18(2):211-7. doi: 10.1016/j.ejon.2013.10.007. Epub 2013 Nov 28.

PMID:
24290535
20.

Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia.

Alazzam M, Tidy J, Osborne R, Coleman R, Hancock BW, Lawrie TA.

Cochrane Database Syst Rev. 2012 Dec 12;12:CD008891. doi: 10.1002/14651858.CD008891.pub2. Review. Update in: Cochrane Database Syst Rev. 2016;1:CD008891.

PMID:
23235667
21.

Ectopic gestational trophoblastic disease: a case series review.

Hassadia A, Kew FM, Tidy JA, Wells M, Hancock BW.

J Reprod Med. 2012 Jul-Aug;57(7-8):297-300.

PMID:
22838244
22.

Initial presenting features in gestational trophoblastic neoplasia: does a decade make a difference?

Killick S, Cook J, Gillett S, Ellis L, Tidy J, Hancock BW.

J Reprod Med. 2012 Jul-Aug;57(7-8):279-82.

PMID:
22838240
23.

The outcome for women with microinvasive cervical cancer with stromal invasion 1 mm or less: should we always re-excise?

Palmer JE, Amarad P, Ellis K, Dudding N, Smith J, Tidy JA.

Int J Gynecol Pathol. 2012 Sep;31(5):470-4. doi: 10.1097/PGP.0b013e31824a1d8d.

PMID:
22833089
24.

First-line chemotherapy in low-risk gestational trophoblastic neoplasia.

Alazzam M, Tidy J, Hancock BW, Osborne R, Lawrie TA.

Cochrane Database Syst Rev. 2012 Jul 11;(7):CD007102. doi: 10.1002/14651858.CD007102.pub3. Review. Update in: Cochrane Database Syst Rev. 2016;(6):CD007102.

25.

Healthy women with persistently elevated hCG levels: a case series of fourteen women.

Angelopoulos G, Palmer JE, Hancock BW, Tidy JA.

J Reprod Med. 2012 May-Jun;57(5-6):249-53.

PMID:
22696821
26.

Management of microinvasive cervical cancer: a British Society for Colposcopy and Cervical Pathology audit.

Cairns M, Tidy J, Cruickshank ME.

J Low Genit Tract Dis. 2012 Oct;16(4):403-8. doi: 10.1097/LGT.0b013e3182454ab4.

PMID:
22659775
27.

Predicting gestational trophoblastic neoplasia (GTN): is urine hCG the answer?

Alazzam M, Young T, Coleman R, Hancock B, Drew D, Wilson P, Tidy J.

Gynecol Oncol. 2011 Sep;122(3):595-9. doi: 10.1016/j.ygyno.2011.05.035.

PMID:
21684585
28.

Screening for central nervous system disease in metastatic gestational trophoblastic neoplasia.

Price JM, Hancock BW, Tidy J, Everard J, Coleman RE.

J Reprod Med. 2010 Jul-Aug;55(7-8):301-4.

PMID:
20795342
29.

Choriocarcinoma after a nonterm pregnancy.

Macdonald MC, Ram R, Tidy JA, Hancock BW.

J Reprod Med. 2010 May-Jun;55(5-6):213-8.

PMID:
20626177
30.

Pregnancy following vulvar squamous cell carcinoma: a report of two cases.

Palmer JE, Tidy JA.

J Gynecol Oncol. 2009 Dec;20(4):254-6. doi: 10.3802/jgo.2009.20.4.254. Epub 2009 Dec 28.

31.

Gestational trophoblastic neoplasia, an ancient disease: new light and potential therapeutic targets.

Alazzam M, Tidy J, Hancock BW, Powers H.

Anticancer Agents Med Chem. 2010 Feb;10(2):176-85. Review.

PMID:
20015010
32.

Folate status and aberrant DNA methylation are associated with HPV infection and cervical pathogenesis.

Flatley JE, McNeir K, Balasubramani L, Tidy J, Stuart EL, Young TA, Powers HJ.

Cancer Epidemiol Biomarkers Prev. 2009 Oct;18(10):2782-9. doi: 10.1158/1055-9965.EPI-09-0493. Epub 2009 Sep 15.

33.

The detection of cervical intraepithelial neoplasia by electrical impedance spectroscopy: the effects of acetic acid and tissue homogeneity.

Balasubramani L, Brown BH, Healey J, Tidy JA.

Gynecol Oncol. 2009 Nov;115(2):267-71. doi: 10.1016/j.ygyno.2009.08.010. Epub 2009 Sep 9.

34.
35.

First line chemotherapy in low risk gestational trophoblastic neoplasia.

Alazzam M, Tidy J, Hancock BW, Osborne R.

Cochrane Database Syst Rev. 2009 Jan 21;(1):CD007102. doi: 10.1002/14651858.CD007102.pub2. Review. Update in: Cochrane Database Syst Rev. 2012;7:CD007102.

PMID:
19160319
36.

Influence of age as a factor in the outcome of gestational trophoblastic neoplasia.

Palmer JE, Hancock BW, Tidy JA.

J Reprod Med. 2008 Aug;53(8):565-74.

PMID:
18773619
37.

Role of hysterectomy in managing persistent gestational trophoblastic disease.

Alazzam M, Hancock BW, Tidy J.

J Reprod Med. 2008 Jul;53(7):519-24.

PMID:
18720927
38.

Epithelioid trophoblastic tumor: a review of the literature.

Palmer JE, Macdonald M, Wells M, Hancock BW, Tidy JA.

J Reprod Med. 2008 Jul;53(7):465-75. Review.

PMID:
18720920
39.

Impedance spectral measurements made through a membrane infection barrier.

Brown BH, Gonzalez-Correa CA, Bremner J, Tidy JA.

Med Biol Eng Comput. 2006 Dec;44(12):1085-91. Epub 2006 Nov 9.

PMID:
17093953
40.

Postpartum choriocarcinoma presentation, management and survival.

Nugent D, Hassadia A, Everard J, Hancock BW, Tidy JA.

J Reprod Med. 2006 Oct;51(10):819-24.

PMID:
17086810
41.
42.

Placental site trophoblastic tumour: clinical features and management.

Hassadia A, Gillespie A, Tidy J, Everard R G N J, Wells M, Coleman R, Hancock B.

Gynecol Oncol. 2005 Dec;99(3):603-7. Epub 2005 Aug 8.

PMID:
16085293
43.

Oestradiol and FSH in gestational trophoblastic disease: a prospective analysis of their predictive value.

Macdonald R, Kirwan J, Thomson C, Hancock B, Everard J, Tidy J.

BJOG. 2005 Jul;112(7):977-80.

44.
45.

Gestational trophoblastic disease: is intensive follow up essential in all women?

Pisal N, Tidy J, Hancock B.

BJOG. 2004 Dec;111(12):1449-51.

46.

Appraisal theory and emotional sequelae of first visit to colposcopy following an abnormal cervical screening result.

Orbell S, Hagger M, Brown V, Tidy J.

Br J Health Psychol. 2004 Nov;9(Pt 4):533-55.

PMID:
15509360
47.

Role of hysterectomy in management of gestational trophoblastic disease.

Pisal N, North C, Tidy J, Hancock B.

Gynecol Oncol. 2002 Nov;87(2):190-2.

PMID:
12477450
48.

Forgotten implications of HPV positivity for the majority of females: a clinical perspective.

Tidy J.

Cytopathology. 2002 Oct;13(5):263-6. Review. No abstract available.

PMID:
12421441
49.

Current management of molar pregnancy.

Hancock BW, Tidy JA.

J Reprod Med. 2002 May;47(5):347-54. Review.

PMID:
12063873
50.

Coincident inactivation of 14-3-3sigma and p16INK4a is an early event in vulval squamous neoplasia.

Gasco M, Sullivan A, Repellin C, Brooks L, Farrell PJ, Tidy JA, Dunne B, Gusterson B, Evans DJ, Crook T.

Oncogene. 2002 Mar 14;21(12):1876-81.

Supplemental Content

Loading ...
Support Center